On the other hand, we discovered that exosomal LINC00917 was significantly upregulated in stage III/IV NSCLC patients than in stage I/II NSCLC patients (Figure 2E, p = 0.001). This evidence concerns the gene LINC00917 and non-small cell lung carcinoma.